Skip to main content
Log in

Regio- and Stereoselective 1,3-dipolar Cycloaddition of Azomethine Ylides Based on Isatins and (thia)proline to 3-nitro-2-(trifluoro(trichloro)methyl)-2H-chromenes: Synthesis and Cytotoxic Activity of 6-(trihalomethyl)-spiro[chromeno(thia)pyrrolizidine-11,3'-indolin]-2'-ones

  • Published:
Chemistry of Heterocyclic Compounds Aims and scope

A regio- and stereoselective method for the synthesis of (trifluoro(trichloro)methyl)-substituted spiro[chromeno(thia)pyrrolizidineoxindoles] in 53–97% yields was developed on the basis of the three-component reaction of 3-nitro-2-(trifluoro(trichloro)methyl)-2Hchromenes with azomethine ylides generated in situ from isatins and L-(thia)proline in EtOH at 30°C. The obtained compounds demonstrated high cytotoxic activity against HeLa human cervical cancer and RD human embryonic rhabdomyosarcoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1.
Figure 2.
Figure 3.

Similar content being viewed by others

References

  1. (a) Korotaev, V. Yu.; Kutyashev, I. B.; Barkov, A. Yu.; Sosnovskikh, V. Ya. Russ. Chem. Rev. 2019, 88, 27. [Usp. Khim. 2019, 88, 27.] (b) Vroemans, R.; Dehaen, W. In Targets in Heterocyclic Systems; Attanasi, O. A.; Merino, P.; Spinelli, D., Eds.; Società Chimica Italiana: Rome, 2018, Vol. 22, p. 318. b Korotaev, V. Yu.; Sosnovskikh, V. Ya.; Barkov, A. Yu. Russ. Chem. Rev. 2013, 82, 1081. [Usp. Khim. 2013, 82, 1081.]

  2. (a) Pratap, R.; Ram, V. J. Chem. Rev. 2014, 114, 10476. (b) O'Connor, C. J.; Beckmann, H. S. G.; Spring, D. R. Chem. Soc. Rev. 2012, 41, 4444. (c) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893. (d) Costa, M.; Dias, T. A.; Brito, A.; Proença, F. Eur. J. Med. Chem. 2016, 123, 487.

  3. (a) Elomri, A.; Skaltsounis, A.-L.; Michel, S.; Tillequin, F.; Koch, M.; Rolland, Y.; Pierré, A.; Atassi, G. Chem. Pharm. Bull. 1996, 44, 2165. (b) Han, K.; Xu, X.; Chen, G.; Zeng, Y.; Zhu, J.; Du, X.; Zhang, Z.; Cao, B.; Liu, Z.; Mao, X. J. Hematol. Oncol. 2014, 7, 9. (c) Jean, M.; Fouque, A.; Legembre, P.; van de Weghe, P. EP Patent 2853530A1. (d) Wang, S.; Li, J.; Du, Y.; Xu, Y.; Wang, Y.; Zhang, Z.; Xu, Z.; Zeng, Y.; Mao, X.; Cao, B. J. Farmacol. Sci. 2017, 134, 197. (e) Fouqué, A.; Delalande, O.; Jean, M.; Castellano, R.; Josselin, E.; Malleter, M.; Shoji, K. F.; Hung, M. D.; Rampanarivo, H.; Collette, Y.; van de Weghe, P.; Legembre, P. J. Med. Chem. 2015, 58, 6559.

  4. (a) Hartmann, T.; Witte, L. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Pergamon: Oxford, 1995, Vol. 9, p. 155. (b) Bull, L. В.; Culvenor, C. C. J.; Dick, A. Т. The Pyrrolizidine Alkaloids: Their Chemistry, Pathogenicity and Other Biological Properties; John Wiley & Sons: New York, 1968. (c) Robertson, J.; Stevens, K. Nat. Prod. Rep. 2017, 34, 62. (d) Cakmak, M.; Mayer, P.; Trauner, D. Nat. Chem. 2011, 3, 543. (e) Becker, D. P.; Flynn, D. L.; Moormann, A. E.; Nosal, R.; Villamil, C. I.; Loeffler, R.; Gullikson, G. W.; Moummi, C.; Yang, D.-C. J. Med. Chem. 2006, 49, 1125. (f) Miyano, S.; Sumoto, K.; Satoh, F.; Shima, K.; Hayashimatsu, M.; Morita, M.; Aisaka, K.; Noguchi, T. J. Med. Chem. 1985, 28, 714. (g) Sakai, R.; Inoue, D.; Ishibashi, K.; Inoue, M.; Shirayama, T.; Asayama, J.; Nakagawa, M. J. Cardiovasc. Farmacol. 1995, 25, 953.

  5. (a) Boddy, A. J.; Bull, J. A. Org. Chem. Front. 2021, 8, 1026. (b) Izmest'ev, A. N.; Gazieva, G. А.; Kravchenko, A. N. Chem. Heterocycl. Compd. 2020, 56, 255. [Khim. Geterotsikl. Soedin. 2020, 56, 255.] (c) Gataullin, R. R. Helv. Chim. Acta 2020, 103, e2000137. c Nájera, C.; Sansano, J. M. Pure Appl. Chem. 2019, 91, 575.

  6. (a) Yu, B.; Yu, D.-Q.; Liu, H.-M. Eur. J. Med. Chem. 2015, 97, 673. (b) Ding, K.; Lu, Y.; Nikolovska-Coleska, Z.; Qiu, S.; Ding, Y.; Gao, W.; Stuckey, J.; Roller, P. P.; Tomita, Y.; Deschamps, J. R.; Wang, S. J. Am. Chem. Soc. 2005, 127, 10130. (c) Ding, K.; Lu, Y.; Nikolovska-Coleska, Z.; Wang, G.; Qiu, S.; Shangary, S.; Gao, W.; Qin, D.; Stuckey, J.; Krajewski, K.; Roller, P. P.; Wang, S. J. Med. Chem. 2006, 49, 3432. (d) Ivanenkov, Y. A.; Vasilevski, S. V.; Beloglazkina, E. K.; Kukushkin, M. E.; Machulkin, A. E.; Veselov, M. S.; Chufarova, N. V.; Chernyagina, E. S.; Vanzcool, A. S.; Zyk, N. V.; Skvortsov, D. A.; Khutornenko, A. A.; Rusanov, A. L.; Tonevitsky, A. G.; Dontsova, O. A.; Majouga, A. G. Bioorg. Med. Chem. Lett. 2015, 25, 404. (e) Wang, S.; Sun, W.; Zhao, Y.; McEachern, D.; Meaux, I.; Barrière, C.; Stuckey, J. A.; Meagher, J. L.; Bai, L.; Liu, L.; Hoffman-Luca, C. G.; Lu, J.; Shangary, S.; Yu, S.; Bernard, D.; Aguilar, A.; Dos-Santos, O.; Besret, L.; Guerif, S.; Pannier, P.; Gorge-Bernat, D.; Debussche, L. Cancer Res. 2014, 74, 5855.

  7. (a) Arumugam, N.; Kumar, R. S.; Almansour, A. I.; Perumal, S. Curr. Org. Chem. 2013, 17, 1929. (b) Döndas, H. A.; Retamosa, M. G.; Sansano, J. M. Synthesis 2017, 2819. (c) Korotaev, V. Yu.; Zimnitskiy, N. S.; Barkov, A. Yu.; Kutyashev, I. B.; Sosnovskikh, V. Ya. Chem. Heterocycl. Compd. 2018, 54, 905. [Khim. Geterotsikl. Soedin. 2018, 54, 905.] (d) Singh, R.; Bhardwaj, D.; Saini, M. R. RSC Adv. 2021, 11, 4760. d Arumugam, N.; Almansour, A. I.; Kumar, R. S.; Ali Al-Aizari, A. J. M.; Alaqeel, S. I.; Kansız, S.; Krishna,V. S.; Sriram, D.; Dege, N. RSC Adv. 2020, 10, 23522. e Rao, M. P.; Gunaga, S. S.; Zuegg, J.; Pamarthi, R.; Ganesh, M. Org. Biomol. Chem. 2019, 17, 9390. f Chornous, V. A.; Mel'nik, O. Ya.; Mel'nik, D. A.; Rusanov, E. B.; Vovk, M. V. Russ. J. Org. Chem. 2015, 51, 1423. [Zh. Org. Khim. 2015, 51, 1454.] (h) Bakthadoss, M.; Sivakumar, N.; Devaraj, A.; Sharada, D. S. Synthesis 2011, 2136.

  8. Kutyashev, I. B.; Ulitko, M. V.; Barkov, A. Yu.; Zimnitskiy, N. S.; Korotaev, V. Yu.; Sosnovskikh, V. Ya. New J. Chem. 2019, 43, 18495.

    Article  CAS  Google Scholar 

  9. Korotaev, V. Yu.; Barkovskiy, S V.; Kutyashev, I. B.; Ulitko, M. V.; Barkov, A. Yu.; Zimnitskiy, N. S.; Kochnev, I. A.; Sosnovskikh, V. Ya. Chem. Heterocycl. Compd. 2021, 57, 679. [Khim. Geterotsikl. Soedin. 2021, 57, 679.]

  10. (a) Kutyashev, I. B.; Barkov, A. Yu.; Korotaev, V. Yu.; Sosnovskikh, V. Ya. Chem. Heterocycl. Compd. 2019, 55, 529. [Khim. Geterotsikl. Soedin. 2019, 55, 529.] (b) Korotaev, V. Yu.; Kutyashev, I. B.; Barkov, A. Yu.; Rozhkova, Yu. S.; Plekhanova, I. V.; Shklyaev, Yu. V.; Sosnovskikh, V. Ya. Tetrahedron Lett. 2019, 60, 150916. b Kutyashev, I. B.; Barkov, A. Yu.; Zimnitskiy, N. S.; Korotaev, V. Yu.; Sosnovskikh, V. Ya. Chem. Heterocycl. Compd. 2019, 55, 861. [Khim. Geterotsikl. Soedin. 2019, 55, 861.] (d) Kutyashev, I. B.; Kochnev, I. А.; Cherepkova, A. А.; Zimnitskiy, N. S.; Barkov, A. Yu; Korotaev, V. Yu.; Sosnovskikh, V. Ya. Chem. Heterocycl. Compd. 2020, 56, 1302. [Khim. Geterotsikl. Soedin. 2020, 56, 1302.] (e) Kutyashev, I. B.; Sannikov, M. S.; Kochnev, I. A.; Barkov, A. Yu.; Zimnitskiy, N. S.; Korotaev, V. Yu.; Sosnovskikh, V. Ya. SynOpen 2021, 5, 1.

  11. Rao, J. N. S.; Raghunathan, R. Tetrahedron Lett. 2013, 54, 6568.

    Article  Google Scholar 

  12. Nayak, S.; Mishra, S. K.; Bhakta, S.; Panda, P.; Baral, N.; Mohapatra, S.; Purohit, C. S.; Satha, P. Lett. Org. Chem. 2016, 13, 11.

    Article  CAS  Google Scholar 

  13. (a) Grigg, R.; Idle, J.; McMeekin, P.; Surendrakumar, S.; Vipond, D. J. Chem. Soc., Perkin Trans. 1 1988, 2703. (b) Toma, Y.; Kunigami, M.; Watanabe, K.; Higashi, M.; Arimitsu, S. J. Fluorine Chem. 2016, 189, 22. (c) Sobhi, C.; Nacereddine, A. K.; Djerourou, A.; Ríos-Gutiérrez, M; Domingo, L. R. J. Phys. Org. Chem. 2017, 30, e3637.

  14. Korotaev, V. Yu.; Barkov, A. Yu.; Moshkin, V. S.; Matochkina, E. G.; Kodess, M. I.; Sosnovskikh, V. Ya. Tetrahedron 2013, 69, 8602.

    Article  CAS  Google Scholar 

  15. Wall, M. E.; Wani, M. C.; Cook, C. E.; Palmer, K. H.; McPhail, A. T.; Sim, G. A. J. Am. Chem. Soc. 1966, 88, 3888.

    Article  CAS  Google Scholar 

  16. Korotaev, V. Yu.; Kutyashev, I. B.; Sosnovskikh, V. Ya. Heteroat. Chem. 2005, 16, 492.

    Article  CAS  Google Scholar 

  17. Sheldrick, G. M. Acta Crystallogr., Sect. A: Found. Crystallogr. 2008, A64, 112.

  18. Mosmann, T. J. Immunol. Methods 1983, 65, 55.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vladislav Yu. Korotaev.

Additional information

Translated from Khimiya Geterotsiklicheskikh Soedinenii, 2021, 57(7/8), 751–763

Supplementary Information

ESM 1

(PDF 5905 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kutyashev, I.B., Ulitko, M.V., Barkov, A.Y. et al. Regio- and Stereoselective 1,3-dipolar Cycloaddition of Azomethine Ylides Based on Isatins and (thia)proline to 3-nitro-2-(trifluoro(trichloro)methyl)-2H-chromenes: Synthesis and Cytotoxic Activity of 6-(trihalomethyl)-spiro[chromeno(thia)pyrrolizidine-11,3'-indolin]-2'-ones. Chem Heterocycl Comp 57, 751–763 (2021). https://doi.org/10.1007/s10593-021-02979-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10593-021-02979-3

Keywords

Navigation